德克斯梅德托米丁在 Paroxysmal 交感性过活性的作用: 一个系统的审查
Cole R Jerousek1, Justin P Reinert1
1The University of Toledo College of Pharmacy and Pharmaceutical Sciences, Toledo, OH, USA.
The Annals of pharmacotherapy
|August 23, 2023
概括
德克斯梅德托米丁有效地治疗和预防患者,特别是那些有创伤性脑损伤 (TBI) 患者的 Paroxysmal Sympathetic Hyperactivity (PSH). 这次审查发现,德克斯梅德托米丁是安全有效的,报告的不良事件很少.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 关键护理医学 关键护理医学
背景情况:
- 松性交感性过活性 (PSH) 是一种严重的疾病,其特征是交感性过活性的发作.
- 对PSH有效的管理策略至关重要,特别是在神经损伤患者中.
- 德克斯梅德托米丁是一种α-2上腺激动剂,在管理自主功能障碍方面具有潜在的应用.
研究的目的:
- 系统地评估德克斯梅德托米丁在治疗和预防PSH方面的疗效和安全性.
- 综合目前关于德克斯梅德托米丁在PSH管理中的作用的证据.
- 为了确定关于PSH中德克斯梅德米丁最佳使用的知识差距.
主要方法:
- 在多个数据库 (Embase,MEDLINE,Cochrane CENTRAL等) 中进行了全面的文献搜索. 通过2023年6月.
- 包括报告德克斯梅德托米丁在PSH患者中有效性或安全性数据的研究.
- 分析了成年人群的观测研究,其中包含定量/质量结局数据.
主要成果:
- 包括13项涉及178名患者的观察性研究.
- 在急性治疗期间,德克斯梅德托米丁在48名患者中44名患者的PSH频率或严重程度降低方面表现出有效性.
- 预防性使用德克斯梅德托米丁与TBI后患者的PSH-Assessment Measure得分改善有关.
- 没有或很少的不良事件被报告与德克斯梅德托米丁使用.
结论:
- 德克斯梅德托米丁是治疗和预防PSH的安全有效选择.
- 有证据支持其用于创伤性脑损伤 (TBI) 患者.
- 需要进一步的研究来确定最佳剂量,并了解PSH病因与治疗疗效之间的相关性.
更多相关视频
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
15.7K
04:51Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
Published on: April 11, 2019
9.4K
相关概念视频
01:30Adrenergic Agonists: Therapeutic Uses
841
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
841
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
202
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
202
01:30Adrenergic Agonists: Direct-Acting Agents
1.6K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
1.6K
01:19Depolarizing Blockers: Pharmocokinetics
353
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
353
01:24Parkinson's Disease: Treatment
297
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
297
01:28Adrenergic Agonists: Mixed-Action Agents
778
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
778